Acute leukemia of ambiguous lineage, biphenotype, without CD34, TdT or TCR-rearrangement

7Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Biphenotypic acute leukemia (BAL) is a rare entity that comprises 0.5-3% of all acute leukemias and probably arises from multipotent progenitor cells. The optimal approach for BAL therapy is unknown. Thus, it is important to elucidate the origin of the neoplastic cells for determination of the appropriate therapy. We report the case of a 41-year-old man with BAL having myeloid and T-lymphoid lineage phenotypes. Strangely, neither CD34 nor TdT expression nor rearrangement of TCR-α/β, δ/γ genes were shown. This pattern is rarely encountered and suggests that the blast cells were possibly considered immature with aspects of differentiation indicating myeloid lineage, rather than T-lymphoid lineage. © 2009 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Nishiuchi, T., Ohnishi, H., Kamada, R., Kikuchi, F., Shintani, T., Waki, F., … Ishida, T. (2009). Acute leukemia of ambiguous lineage, biphenotype, without CD34, TdT or TCR-rearrangement. Internal Medicine, 48(16), 1437–1441. https://doi.org/10.2169/internalmedicine.48.2329

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free